期刊
MOLECULES
卷 24, 期 19, 页码 -出版社
MDPI
DOI: 10.3390/molecules24193422
关键词
Thienopyrimidine; Pyrazole; PI3K alpha inhibitor
资金
- National Natural Science Funds [21967009]
- Natural Science Foundation of Jiangxi, China [20171ACB21052, 2018BBG70003]
- Natural Science Funds for Distinguished Young Scholar of Jiangxi Province, China [20171BCB23078]
- Key projects of the youth fund, Natural Science Funds of Jiangxi Province [20171ACB21052]
Three series of novel thienopyrimidine derivatives 9a-l, 15a-l, and 18a-h were designed and synthesized, and their IC50 values against four cancer cell lines HepG-2, A549, PC-3, and MCF-7 were evaluated. Most compounds show moderate cytotoxicity against the tested cancer cell lines. The most promising compound 9a showed moderate activity with IC50 values of 12.32 +/- 0.96, 11.30 +/- 1.19, 14.69 +/- 1.32, and 9.80 +/- 0.93 mu M, respectively. The inhibitory activities of compounds 9a and 15a against PI3K alpha and mTOR kinase were further evaluated. Compound 9a exhibited PI3K alpha kinase inhibitory activity with IC50 of 9.47 +/- 0.63 mu M. In addition, docking studies of compounds 9a and 15a were also investigated.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据